This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Transparency, Aggregate Spend & HCP Engagement 2025
Delivered as a Hybrid Event August 12-14 2025
The Ritz-Carlton, Tysons CornerMcLean, VA

Brian Bohnenkamp
Partner, FDA & Life Sciences at King & Spalding
Speaker

Profile

Brian specializes in regulatory and compliance matters relating to drug, biotechnology and medical device companies. A partner in King & Spalding’s FDA practice, he has extensive experience counseling manufacturers on fraud and abuse laws, industry codes of conduct, federal and state transparency laws and regulations, state and local gift bans, compliance program laws and sales representative licensing requirements, as well as government ethics restrictions. Brian also counsels and represents manufacturers defending government investigations into alleged violations of the Anti-Kickback Statute and False Claims Act.

Agenda Sessions

  • Mock Open Payments Audit — A Multi-Stakeholder Walk-Through to Ensure Audit-Readiness

    9:00am